25Jul/13

The Multiple Sclerosis Market Will Grow 10 Percent Annually Through 2018 As … – PR Newswire (press release)

The Multiple Sclerosis Market Will Grow 10 Percent Annually Through 2018 As
PR Newswire (press release)
be followed by the emergence of more-convenient reformulations of platform injectables and three highly efficacious monoclonal antibodies— Genzyme/Bayer HealthCare’s Lemtrada, Roche/Genentech’s ocrelizumab and Biogen Idec/AbbVie’s daclizumab.

and more »

25Jul/13

Dubai: Nama Tuluveru to hold blood donation campaign Jul 28 – Daijiworld.com

Dubai: Nama Tuluveru to hold blood donation campaign Jul 28
Daijiworld.com
Dubai, Jul 25: Nama Tuluveru UAE a charity based organisation in UAE has come forward to support “Donate Blood save a Life Campaign’ which will be held on Sunday the July 28 7.30 pm onwards at Latifa Hospital (old Al Wasl Hospital) Dubai. This is a 
Dubai : Billawas Dubai & NE to conduct Blood Donation Campaign 30th JulyBellevision

all 4 news articles »

25Jul/13

Biogen Idec, Inc. (BIIB) Tops Q2 EPS by 37c; Issues Solid Guidance – StreetInsider.com (subscription)

Biogen Idec, Inc. (BIIB) Tops Q2 EPS by 37c; Issues Solid Guidance
StreetInsider.com (subscription)
generated from underlying patient demand was approximately $110 million. RITUXAN® (rituximab) revenues from our unconsolidated joint business arrangement were $289 million for the quarter, an increase of 1% compared to the second quarter of 2012.

and more »